Chemo-Free Drug Shows Major Survival, Remission Gains In Relapsed Multiple Myeloma

WEDNESDAY, June 3, 2026— A recently approved cancer immunotherapy can put nearly two-thirds of people with relapsed multiple myeloma into complete remission, a new clinical trial has found.About 70% of patients treated with teclistamab (Tecvayli)...